R&D Engineer

Axel Kattar obtained his bachelors (2017) and masters (2019) degree from the university of Twente in chemical engineering. He was part of the ORBITAL project as a Marie Curie fellow and obtained a doctorate at the University of Santiago de Compostela looking into ocular drug delivery through the use of nanoparticles to treat diabetic eye diseases.